Xeris Biopharma Holdings (XERS) Selling, General & Administrative (2020 - 2026)
Xeris Biopharma Holdings (XERS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.50 Bn | 1.38 Bn | 79.59 Mn | 61.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.04 Mn |
| Mar 31, 2026 | 53.14 Mn |
| Dec 31, 2025 | 47.50 Mn |
| Sep 30, 2025 | 46.46 Mn |
| Jun 30, 2025 | 44.39 Mn |
| Mar 31, 2025 | 44.02 Mn |
| Dec 31, 2024 | 40.14 Mn |
| Sep 30, 2024 | 44.97 Mn |
| Jun 30, 2024 | 39.99 Mn |
| Mar 31, 2024 | 38.38 Mn |
| Dec 31, 2023 | 37.57 Mn |
| Sep 30, 2023 | 37.29 Mn |
| Jun 30, 2023 | 37.64 Mn |
| Mar 31, 2023 | 33.61 Mn |
| Dec 31, 2022 | 34.36 Mn |
| Sep 30, 2022 | 34.49 Mn |
| Jun 30, 2022 | 32.98 Mn |
| Mar 31, 2022 | 35.91 Mn |
| Dec 31, 2021 | 54.18 Mn |
| Sep 30, 2021 | 26.54 Mn |